Victory Medical Center Pharmacy has issued a voluntary nationwide recall of certain lots of compounded glutathione 200 mg/mL multi-dose vials after internal testing identified elevated bacterial endotoxin levels. The Austin, Texas pharmacy said the recall, announced August 5, 2026, applies at the patient level and covers three lots of the injectable product.
The recalled vials are labeled VMC Compounded Glutathione 200 mg/mL, multi-dose, with lot numbers 1980571, 1981940 and 1984345, all bearing an expiration date of August 27, 2026. The product was distributed to consumers in Texas, Florida and New York.
Victory Medical Center Pharmacy said injectable products with elevated endotoxin levels carry a “reasonable probability” of causing significant medical events, including fever, hypotension, inflammatory reactions, anaphylactic shock and death. To date, the pharmacy has received reports of adverse events such as fever, chills, severe headache, nausea, vomiting, tachycardia, changes in blood pressure, body aches and injection site reactions.
Patients who have product from an affected lot are urged to stop using it immediately and quarantine any vials subject to the recall. The pharmacy is notifying prescribers and patients by telephone and mail and arranging retrieval and proper disposal of the recalled product. Patients and prescribers will receive a full refund if they have not already been reimbursed.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!